KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Vertex Pharmaceuticals (VRTX) over the last 16 years, with Q3 2025 value amounting to 0.48.

  • Vertex Pharmaceuticals' Asset Utilization Ratio fell 439.73% to 0.48 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.48, marking a year-over-year decrease of 439.73%. This contributed to the annual value of 0.49 for FY2024, which is 85.07% up from last year.
  • According to the latest figures from Q3 2025, Vertex Pharmaceuticals' Asset Utilization Ratio is 0.48, which was down 439.73% from 0.49 recorded in Q2 2025.
  • In the past 5 years, Vertex Pharmaceuticals' Asset Utilization Ratio registered a high of 0.58 during Q4 2021, and its lowest value of 0.44 during Q1 2024.
  • In the last 5 years, Vertex Pharmaceuticals' Asset Utilization Ratio had a median value of 0.5 in 2023 and averaged 0.51.
  • Per our database at Business Quant, Vertex Pharmaceuticals' Asset Utilization Ratio crashed by 1484.93% in 2023 and then surged by 1194.19% in 2025.
  • Vertex Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.58 in 2021, then decreased by 11.88% to 0.51 in 2022, then fell by 13.35% to 0.44 in 2023, then increased by 10.87% to 0.49 in 2024, then dropped by 2.59% to 0.48 in 2025.
  • Its last three reported values are 0.48 in Q3 2025, 0.49 for Q2 2025, and 0.49 during Q1 2025.